Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
-
LogicBio Therapeutics (LOGC) Announces Proposed Common Offering
-
LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
-
LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
LogicBio Therapeutics to Present at October Conferences
-
LogicBio Therapeutics to Present at October Conferences
-
Chardan Capital Markets Starts LogicBio Therapeutics (LOGC) at Buy
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
Chardan Serves as Lead Manager for LogicBio Therapeutics

